Top 10 Companies in the Global Newborn Screening and Genetic Services Market (2026): Market Leaders Shaping Early Diagnosis

In Business Insights
November 17, 2026

Global Newborn Screening and Genetic Services market was valued at USD million in 2025 and is projected to reach USD million by 2034, at a CAGR of % during the forecast period.

The USA market for Global Newborn Screening and Genetic Services market is estimated to increase from USD million in 2025 to reach USD million by 2034, at a CAGR during the forecast period of 2025 through 2034.

The China market for Global Newborn Screening and Genetic Services market is estimated to increase from USD million in 2025 to reach USD million by 2034, at a CAGR during the forecast period of 2025 through 2034.

The Europe market for Global Newborn Screening and Genetic Services market is estimated to increase from USD million in 2025 to reach USD million by 2034, at a CAGR during the forecast period of 2025 through 2034.

Report Overview
Newborn Screening and Genetic Services encompass a range of medical tests and genetic analyses performed on newborns to detect congenital disorders, metabolic conditions, and genetic diseases early in life.
This report provides a deep insight into the global Newborn Screening and Genetic Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Newborn Screening and Genetic Services Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Newborn Screening and Genetic Services market in any manner.

Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

  • Trivitron Healthcare
  • MASIMO CORPORATION
  • Covidien Plc
  • Nemours KidsHealth
  • NJ.gov
  • Agilent Technologies
  • GE Healthcare
  • PERKINELMER
  • Natus Medical Incorporated
  • Waters

Market Segmentation (by Type)

  • Dry Blood Spot Tests
  • Hearing Screening Tests
  • Cchd Screening Tests
  • Other

Market Segmentation (by Application)

  • Clinical Laboratories
  • Hospitals
  • Other

Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Newborn Screening and Genetic Services Market
• Overview of the regional outlook of the Newborn Screening and Genetic Services Market:

Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Newborn Screening and Genetic Services Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market’s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter’s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Global Newborn Screening and Genetic Services Market – View in Detailed Research Report

🔟 1. Trivitron Healthcare

Headquarters: Waltham, Massachusetts, USA
Key Offering: Integrated newborn screening platforms and data analytics solutions

Trivitron’s flagship product, the Triage™ platform, consolidates laboratory workflows and delivers rapid, actionable results for metabolic and genetic disorders. The company’s focus on digital integration allows laboratories to manage test volumes, track turnaround times, and comply with regulatory reporting in a single interface.

Sustainability & Growth Initiatives:

  • Expansion of cloud‑based data storage to support real‑time monitoring of newborn health metrics
  • Partnerships with public health agencies to scale screening coverage in underserved regions
  • Investment in AI‑driven predictive analytics to refine screening algorithms and reduce false positives

🔟 2. MASIMO CORPORATION

Headquarters: Waltham, Massachusetts, USA
Key Offering: Pulse oximetry and newborn screening instrumentation

MASIMO’s Masimo Rainbow® Pulse Oximetry technology provides non‑invasive cardiac screening, a cornerstone of newborn screening programs worldwide. The company’s continuous innovation in sensor technology enhances accuracy, especially in low‑resource settings.

Sustainability & Growth Initiatives:

  • Deployment of low‑cost, battery‑powered devices in rural clinics to increase screening reach
  • Collaboration with international health bodies to develop standardized screening protocols
  • Research into wearable sensors for longitudinal monitoring of infant health

🔟 3. Covidien Plc

Headquarters: Dublin, Ireland
Key Offering: Point‑of‑care diagnostic kits for metabolic disorders

Covidien’s rapid test kits enable on‑site screening for conditions such as phenylketonuria and congenital hypothyroidism. By reducing sample transport times, the company helps laboratories deliver faster results and improve patient outcomes.

Sustainability & Growth Initiatives:

  • Development of multiplexed assays that combine several screening tests into a single cartridge
  • Strategic alliances with national health ministries to standardize newborn screening protocols
  • Investment in sustainable packaging to lower environmental impact of disposable kits

🔟 4. Nemours KidsHealth

Headquarters: Orlando, Florida, USA
Key Offering: Comprehensive newborn health information portal and screening support tools

Nemours provides a digital platform that educates parents and healthcare providers on screening schedules, interpretation of results, and follow‑up care. The portal’s integration with electronic health records streamlines communication between clinicians and families.

Sustainability & Growth Initiatives:

  • Expansion of multilingual content to support diverse populations
  • Partnerships with telehealth providers to offer remote counseling for screening results
  • Data‑driven outreach programs targeting high‑risk communities

🔟 5. NJ.gov

Headquarters: Trenton, New Jersey, USA
Key Offering: State‑level newborn screening program administration

New Jersey’s Department of Health oversees one of the most comprehensive newborn screening programs in the United States, coordinating testing, data collection, and follow‑up across a network of laboratories and hospitals.

Sustainability & Growth Initiatives:

  • Implementation of blockchain for secure data sharing among laboratories
  • Investment in statewide education campaigns to increase screening uptake
  • Policy advocacy for expanded coverage of emerging genetic tests

🔟 6. Agilent Technologies

Headquarters: Santa Clara, California, USA
Key Offering: High‑throughput sequencing platforms for newborn genomics

Agilent’s next‑generation sequencing solutions enable comprehensive genomic profiling of newborns, facilitating the detection of rare inherited disorders beyond the scope of traditional screening panels.

Sustainability & Growth Initiatives:

  • Development of low‑cost sequencing workflows for large‑scale population screening
  • Collaboration with research institutions to refine variant interpretation pipelines
  • Adoption of renewable energy sources in manufacturing facilities

🔟 7. GE Healthcare

Headquarters: Chicago, Illinois, USA
Key Offering: Integrated newborn screening and imaging solutions

GE Healthcare combines biochemical assays with advanced imaging modalities to provide a holistic view of newborn health, supporting early intervention strategies.

Sustainability & Growth Initiatives:

  • Integration of AI for automated image analysis in neonatal units
  • Partnerships with global health organizations to standardize screening protocols
  • Implementation of green manufacturing practices across product lines

🔟 8. PERKINELMER

Headquarters: Boston, Massachusetts, USA
Key Offering: Automated laboratory instrumentation for newborn screening

PERKINELMER’s instruments automate sample handling, reducing error rates and increasing throughput for high‑volume screening laboratories.

Sustainability & Growth Initiatives:

  • Development of energy‑efficient liquid handling systems
  • Collaboration with academic centers to validate new screening biomarkers
  • Implementation of circular supply chain practices for consumables

🔟 9. Natus Medical Incorporated

Headquarters: Irvine, California, USA
Key Offering: Point‑of‑care hearing screening devices

Natus’s H2S™ and QAcoustic™ systems deliver rapid hearing assessments, a critical component of newborn screening programs aimed at early intervention for hearing loss.

Sustainability & Growth Initiatives:

  • Expansion of low‑cost devices for use in low‑resource settings
  • Partnerships with pediatric hospitals to integrate screening into standard newborn care
  • Investment in research on automated audiometry algorithms

🔟 10. Waters

Headquarters: Milford, Massachusetts, USA
Key Offering: Mass spectrometry solutions for metabolic disorder screening

Waters’ MS/MS platforms enable high‑resolution detection of metabolic biomarkers, supporting the identification of inborn errors of metabolism across diverse populations.

Sustainability & Growth Initiatives:

  • Development of low‑sample‑volume assays to reduce waste
  • Collaboration with global health agencies to standardize screening panels
  • Implementation of energy‑saving protocols in laboratory instruments

Download FREE Sample Report: Global Newborn Screening and Genetic Services Market – View in Detailed Research Report

Get Full Report: Global Newborn Screening and Genetic Services Market – View in Detailed Research Report

🌍 Outlook: The Future of Newborn Screening and Genetic Services

The sector is poised to integrate more advanced genomic technologies and real‑time data analytics, enabling earlier detection and personalized intervention pathways. Regulatory bodies are increasingly mandating expanded panels, while payers are negotiating coverage for next‑generation tests. As data interoperability improves, cross‑border collaborations will accelerate the adoption of best practices and harmonize screening standards worldwide.

📈 Future Trends Shaping the Market

  • Widespread adoption of whole‑genome sequencing in newborn panels, driven by falling sequencing costs and improved bioinformatics pipelines.
  • Integration of artificial intelligence for automated result interpretation and risk stratification.
  • Expansion of telehealth platforms to deliver counseling and follow‑up care in remote areas.
  • Policy initiatives to standardize screening protocols across countries, reducing disparities in coverage.
  • Growth of value‑based reimbursement models that reward early detection and intervention outcomes.